• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. DISTAL ATTACHMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. DISTAL ATTACHMENT Back to Search Results
Model Number MH-588
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Tissue Injury (4559)
Date of Event 03/18/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report is related to the following linked patient identifiers: (b)(6).The device was not returned.Should additional relevant information become available, a supplemental report will be submitted.This report has been submitted by the importer under this mdr report number 2429304-2024-0000312.
 
Event or Problem Description
Olympus reviewed the article "quantification of interstitial cells of cajal and fibrosis during gastric per-oral endoscopic myotomy and its association with clinical outcomes." this was a prospective study of gastroparetic patients who underwent g-poem and intraprocedural pyloric muscle biopsies between (b)(6) 2022 and (b)(6) 2023.Type of adverse events/number of patients.Mucosotomy: 1 patient.This was adequately closed on the mucosal side with placement of two hemostatic clips.
 
Event or Problem Description
Objective: alterations to interstitial cells of cajal (icc) and collagen fibrosis have been implicated in the pathogenesis of gastroparesis.We aimed to evaluate the feasibility and safety of pyloric muscle sampling during gastric peroral endoscopic myotomy (g-poem) and the association between pyloric icc density and degree of fibrosis with clinical outcomes.Patients and methods: this was a single-center prospective study.Icc count was estimated using cd117 stain and trichome for collagen fibrosis.Clinical response to g-poem was defined as an improvement of = 1 point on the gastroparesis cardinal symptom index.Results: fifty-six patients (median age 60 years, 71.4% women) underwent g-poem (100% technical success; 71.4% clinical response).Icc depletion (< 10/high-power field) and fibrosis were encountered in 70.4% and 75% of the cases, respectively.There was no difference in mean icc count between g-poem responders vs.Non-responders (7±3.6 vs.7.7±3.3; p = 0.9).There was no association between icc density or degree of fibrosis with the etiology of gastroparesis, duration of symptoms, gastric emptying rate, or pyloric impedance planimetry.Patients who did not respond to g-poem had a significantly higher degree of moderate/severe fibrosis when compared with those who responded (81.3% vs.25%; p = 0.0002).Conclusions: pyloric muscle biopsies during g-poem was feasible and safe.Icc depletion and pyloric muscle fibrosis are common in gastroparetic patients.The degree of fibrosis may be related to pyloric dysfunction and clinical response to g-poem.Additional studies are needed to confirm these results.Reported adverse event: there was one ae (1.8%).In that patient, a mucosotomy was identified after completion of the pyloromyotomy.This was adequately closed on the mucosal side with placement of two hemostatic clips.
 
Additional Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DISTAL ATTACHMENT
Common Device Name
DISTAL ATTACHMENT
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key19606373
Report Number9614641-2024-01322
Device Sequence Number8084285
Product Code FDS
UDI-Device Identifier04953170047879
UDI-Public04953170047879
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K984358
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Literature,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberMH-588
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/28/2024
Supplement Date Received by Manufacturer06/26/2024
Initial Report FDA Received Date06/25/2024
Supplement Report FDA Received Date07/02/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
EVIS EXERA GASTROINTESTINAL VIDEOSCOPE, GIF-H190.; SINGLE USE ELECTROSURGICAL KNIFE, KD-611L.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-